logo

For the Inventor, By the Inventor

Greensboro, NC, United States of America

Kadum A Al Shareffi

This inventor holds 8 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignees: Wyeth, Progenics Pharmaceuticals, Inc.. Active years: 2013-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kadum A Al Shareffi. Retrieved from https://idiyas.com/inventor/kadum-a-al-shareffi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0


Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 29(Granted Patents)


Location History:

  • North Potomac, MD (US) (2015)
  • Greensboro, NC (US) (2013 - 2019)

Company Filing History:

goldMedal8 out of 1,309 
 
Wyeth
 patents
silverMedal2 out of 71 
 
Progenics Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2013-2019

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 10507206 - Oral formulations and lipophilic salts of methylnaltrexone (2019-12-17),
2. 10376505 - Oral formulations and lipophilic salts of methylnaltrexone (2019-08-13),
3. 10307417 - Oral formulations and lipophilic salts of methylnaltrexone (2019-06-04),
4. 9879024 - Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof (2018-01-30),
5. 9314461 - Oral formulations and lipophilic salts of methylnaltrexone (2016-04-19),
6. 9102680 - Crystal forms of (R)-N-methylnaltrexone bromide and uses thereof (2015-08-11),
7. 8956651 - Oral formulations and lipophilic salts of methylnal trexone (2015-02-17),
8. 8524276 - Oral formulations and lipophilic salts of methylnaltrexone (2013-09-03),

Title: Innovations of Kadum A Al Shareffi

Introduction

Kadum A Al Shareffi is a notable inventor based in Greensboro, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral formulations. With a total of 8 patents to his name, his work has had a considerable impact on medication delivery systems.

Latest Patents

Among his latest patents is the invention related to oral formulations and lipophilic salts of methylnaltrexone. This invention provides compositions comprising methylnaltrexone or a salt thereof, along with various formulations for oral administration. His innovative approach aims to enhance the effectiveness of this medication for patients.

Career Highlights

Kadum has worked with prominent companies in the pharmaceutical industry, including Wyeth and Progenics Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in drug formulations.

Collaborations

Throughout his career, Kadum has collaborated with talented individuals such as Syed Muzafar Shah and Christopher Richard Diorio. These partnerships have fostered a creative environment that has led to the successful development of his patented inventions.

Conclusion

Kadum A Al Shareffi's contributions to pharmaceutical innovations demonstrate his commitment to improving medication delivery systems. His work continues to influence the industry and enhance patient care through effective drug formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…